Next-generation regulatory T cell therapy

LMR Ferreira, YD Muller, JA Bluestone… - Nature reviews Drug …, 2019 - nature.com
Regulatory T cells (Treg cells) are a small subset of immune cells that are dedicated to
curbing excessive immune activation and maintaining immune homeostasis. Accordingly …

[HTML][HTML] The IL-2–IL-2 receptor pathway in health and disease: The role of the soluble IL-2 receptor

J Damoiseaux - Clinical Immunology, 2020 - Elsevier
Abstract The interleukin (IL)-2–IL-2 receptor (IL-2R) pathway is important in immunity, but is
also involved in maintenance of self-tolerance. This paradox is further complicated by …

Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics

CG Brunstein, JS Miller, Q Cao… - Blood, The Journal …, 2011 - ashpublications.org
Acute graft-versus-host disease (aGVHD) is associated with high risk of morbidity and
mortality and is a common complication after double umbilical cord blood (UCB) …

Risk factors for acute GVHD and survival after hematopoietic cell transplantation

M Jagasia, M Arora, MED Flowers… - Blood, The Journal …, 2012 - ashpublications.org
Risk factors for acute GVHD (AGVHD), overall survival, and transplant-related mortality were
evaluated in adults receiving allogeneic hematopoietic cell transplants (1999-2005) from …

Ischemia and reperfusion injury in kidney transplantation: relevant mechanisms in injury and repair

GJ Nieuwenhuijs-Moeke, SE Pischke… - Journal of clinical …, 2020 - mdpi.com
Ischemia and reperfusion injury (IRI) is a complex pathophysiological phenomenon,
inevitable in kidney transplantation and one of the most important mechanisms for non-or …

Immunoregulatory functions of mTOR inhibition

AW Thomson, HR Turnquist, G Raimondi - Nature Reviews …, 2009 - nature.com
The potent immunosuppressive action of rapamycin is commonly ascribed to inhibition of
growth factor-induced T cell proliferation. However, it is now evident that the …

[HTML][HTML] Autoimmune diseases and immune-checkpoint inhibitors for cancer therapy: review of the literature and personalized risk-based prevention strategy

J Haanen, MS Ernstoff, Y Wang, AM Menzies… - Annals of oncology, 2020 - Elsevier
Highlights•Solid organ transplantation (SOT) patients or patients with active ADs have been
largely excluded from ICIs clinical trials because of the risk of allograft rejection or severe …

Rapamycin promotes expansion of functional CD4+ CD25+ FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients

M Battaglia, A Stabilini, B Migliavacca… - The Journal of …, 2006 - journals.aai.org
Abstract CD4+ CD25+ FOXP3+ T regulatory cells (Tregs) are pivotal for the induction and
maintenance of peripheral tolerance in both mice and humans. Rapamycin has been shown …

The immunobiology of CD27 and OX40 and their potential as targets for cancer immunotherapy

SL Buchan, A Rogel… - Blood, The Journal of the …, 2018 - ashpublications.org
In recent years, monoclonal antibodies (mAbs) able to reinvigorate antitumor T-cell immunity
have heralded a paradigm shift in cancer treatment. The most high profile of these mAbs …

Aldehyde dehydrogenase expression drives human regulatory T cell resistance to posttransplantation cyclophosphamide

CG Kanakry, S Ganguly, M Zahurak… - Science translational …, 2013 - science.org
High-dose, posttransplantation cyclophosphamide (PTCy) is an effective strategy for
preventing graft-versus-host disease (GVHD) after allogeneic blood or marrow …